Spyre Therapeutics Inc (SYRE)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

SYRE logo

SYRE Cost of Revenue

Latest reported$0.00
SYRE Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

SYRE cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
0
45,247,000
45,247,000
0
0
0
0
0
0
0
0
0
548,000
490,000
502,000
475,000
497,000
502,000
14,853,000
13,579,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.